Showing results (101-110 of 339) with videos related to

Sort By:
Pageof 34
Annals of Hematology|September 17, 2020
Effect of allogeneic HCT from unrelated donors in AML patients with intermediate- or poor-risk cytogenetics: a retrospective study from the Japanese Society for HCTSatoshi Yamasaki, Jinichi Mori, Junya Kanda, et al.
Cancer Science|September 26, 2022
Attenuated humoral response against SARS-CoV-2 mRNA vaccination in allogeneic stem cell transplantation recipientsTakashi Toya, Yuya Atsuta, Takahiro Sanada, et al.
International Journal of Hematology|June 24, 2021
MPL overexpression induces a high level of mutant-CALR/MPL complex: a novel mechanism of ruxolitinib resistance in myeloproliferative neoplasms with CALR mutationsShunichiro Yasuda, Satoru Aoyama, Ryoto Yoshimoto, et al.
Leukemia Research Reports|May 6, 2020
The sensitivity of the <i>FLT3</i>-ITD detection method is an important consideration when diagnosing acute myeloid leukemiaMasahiro Sakaguchi, Nana Nakajima, Hiroki Yamaguchi, et al.
Annals of Hematology|June 17, 2019
Allogeneic hematopoietic cell transplantation for patients with a history of multiple relapses of acute myeloid leukemiaMasamitsu Yanada, Jinichi Mori, Jun Aoki, et al.
Leukemia & Lymphoma|June 19, 2015
Allogeneic hematopoietic stem cell transplant overcomes poor prognosis of acute myeloid leukemia with myelodysplasia-related changesShuntaro Ikegawa, Noriko Doki, Shuhei Kurosawa, et al.
European Journal of Haematology|December 14, 2005
Molecular analysis of PDGFRalpha/beta genes in core binding factor leukemia with eosinophiliaFumihiko Monma, Kazuhiro Nishii, Felipe Lorenzo, et al.
Bone Marrow Transplantation|July 31, 2021
Newly proposed threshold and validation of white blood cell count at diagnosis for Philadelphia chromosome-positive acute lymphoblastic leukemia: risk assessment of relapse in patients with negative minimal residual disease at transplantation-a report from the Adult Acute Lymphoblastic Leukemia Working Group of the JSTCTYu Akahoshi, Yasuyuki Arai, Satoshi Nishiwaki, et al.
Blood Advances|December 12, 2022
Novel risk assessment for the intensity of conditioning regimen in older patientsYu Akahoshi, Yuma Tada, Emiko Sakaida, et al.
Transplant Immunology|July 3, 2016
Toll-like receptor 1 variation increases the risk of transplant-related mortality in hematologic malignanciesKaori Uchino, Shohei Mizuno, Motonori Mizutani, et al.
Pageof 34